Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-01-09A Multicenter, Randomized, Double-Blind, Placebo-Controlled Exploratory Study to Assess the Effect of Treatment With Prolonged-Release Fampridine (BIIB041) 10 mg Twice Daily on Walking Ability and Balance in Subjects With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-01-09A Randomized, Blinded, Placebo-Controlled, Serial-Cohort, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-12-29ClinicalTrials.gov study NCT03004794
-
CLINICAL_TRIALS study record update · 2016-12-23ClinicalTrials.gov study NCT03001284
-
CLINICAL_TRIALS study record update · 2016-12-14Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-12-08A Randomized, Blinded, Parallel-Group, Phase 1 Study of Pharmacokinetics, Safety and Tolerability of Single Intravenous Doses of BIIB033 (Opicinumab ) Produced by 2 Manufacturing Processes, in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-12-08Self-Management Program Based on Physical Exercises for People With Multiple Sclerosis With Mild Neurological Impairment: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2016-12-07Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients (MS).
-
CLINICAL_TRIALS study record update · 2016-12-06A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
-
CLINICAL_TRIALS study record update · 2016-11-29Expiratory Muscle Training for Persons With Neurodegenerative Disease
-
CLINICAL_TRIALS study record update · 2016-11-29Post-transfusion Platelet Count
-
CLINICAL_TRIALS study record update · 2016-11-25ClinicalTrials.gov study NCT01718392
-
CLINICAL_TRIALS study record update · 2016-11-22ClinicalTrials.gov study NCT02970370
-
CLINICAL_TRIALS study record update · 2016-11-16Does Abnormal Neuromuscular Junction Function Play a Role in the Pathogenesis of Motor Fatigue in Women With Multiple Sclerosis?
-
CLINICAL_TRIALS study record update · 2016-11-11Effects of Neurorehabilitation on Upper Limb Performance and on Fatigue in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-11-09A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-11-04Measuring the Impact of Tecfidera on the Gut Microbiota: Does a Change in the Gut Flora Correlate With Gastrointestinal Disturbances Following Therapy Initiation?
-
CLINICAL_TRIALS study record update · 2016-11-04An Open-Label, Multicenter, Multinational Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) 10 mg Twice Daily on Quality of Life as Reported by Subjects With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-11-01New Automatic Portable Ophthalmology Device
-
CLINICAL_TRIALS study record update · 2016-11-01Intervention Focused on Lower Limbs and Functionality in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-10-31Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group, 9 Month, Equivalence Trial Comparing the Efficacy and Safety and Tolerability of GTR (Synthon BV) to Copaxone® (Teva) in Subjects With Relapsing Remitting Multiple Sclerosis Followed by an Open-label 15 Month GTR Treatment Part Evaluating the Long-term GTR Treatment Effects
-
CLINICAL_TRIALS study record update · 2016-10-28Investigating the Plantar Pressure Distribution in Patient With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-10-26Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-10-26Computerized Cognition Testing and Cognitive Motor Interference in MS
-
CLINICAL_TRIALS study record update · 2016-10-26T and B Cell Responses Across Autoimmune Diseases